Skip to main content
. 2021 Sep 13;13(9):1457. doi: 10.3390/pharmaceutics13091457

Figure 8.

Figure 8

RHS results after treatment for 24 h with PBS, 30% PG, 5% w/v SDS, and blank proposome. (A) Tissue viability (%) measured using MTS assay. (B) IL-α and (C) IL-8 levels measured using ELISA kit. (N = 2, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001).